These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30233055)

  • 1. Targeting prion-like protein spreading in neurodegenerative diseases.
    Zhang Z; Nie S; Chen L
    Neural Regen Res; 2018 Nov; 13(11):1875-1878. PubMed ID: 30233055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions, prion-like prionoids, and neurodegenerative disorders.
    Verma A
    Ann Indian Acad Neurol; 2016; 19(2):169-74. PubMed ID: 27293325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models for prion-like diseases.
    Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
    Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
    Nonaka T
    Brain Nerve; 2019 Nov; 71(11):1209-1214. PubMed ID: 31722306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
    Eraña H; Venegas V; Moreno J; Castilla J
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prions and prion-like pathogens in neurodegenerative disorders.
    Peggion C; Sorgato MC; Bertoli A
    Pathogens; 2014 Feb; 3(1):149-63. PubMed ID: 25437612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion-like disorders: blurring the divide between transmissibility and infectivity.
    Cushman M; Johnson BS; King OD; Gitler AD; Shorter J
    J Cell Sci; 2010 Apr; 123(Pt 8):1191-201. PubMed ID: 20356930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegenerative diseases: expanding the prion concept.
    Walker LC; Jucker M
    Annu Rev Neurosci; 2015 Jul; 38():87-103. PubMed ID: 25840008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions and the potential transmissibility of protein misfolding diseases.
    Kraus A; Groveman BR; Caughey B
    Annu Rev Microbiol; 2013; 67():543-64. PubMed ID: 23808331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.
    Toni M; Massimino ML; De Mario A; Angiulli E; Spisni E
    Front Neurosci; 2017; 11():3. PubMed ID: 28154522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited Review: The role of prion-like mechanisms in neurodegenerative diseases.
    Jaunmuktane Z; Brandner S
    Neuropathol Appl Neurobiol; 2020 Oct; 46(6):522-545. PubMed ID: 31868945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases.
    Hu C; Yan Y; Jin Y; Yang J; Xi Y; Zhong Z
    Neurosci Bull; 2024 Feb; 40(2):241-254. PubMed ID: 37755677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of extracellular vesicles in neurodegenerative diseases.
    Quek C; Hill AF
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1178-1186. PubMed ID: 27659705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could it be that neurodegenerative diseases are infectious?
    Derkinderen P
    Rev Neurol (Paris); 2019; 175(7-8):427-430. PubMed ID: 31358351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis.
    Grad LI; Fernando SM; Cashman NR
    Neurobiol Dis; 2015 May; 77():257-65. PubMed ID: 25701498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.